| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Neuronetics, Inc. | Director | Common Stock | 371,816 | $1,015,057 | $2.73 | 20 Oct 2025 | Direct |
| REPLIGEN CORP | Director | Common Stock | 36,622 | $956,566 | $26.12 | 16 Dec 2025 | Direct |
| G1 Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $2.51 | 18 Sep 2024 | Direct |
| REPLIGEN CORP | Director | Stock Option (Right to Buy) | 3,366 | 16 Dec 2025 | Direct | ||
| G1 Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 18 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RGEN | REPLIGEN CORP | 16 Dec 2025 | 2 | +$87,920 | 4 | Director | 17 Dec 2025, 16:30 |
| STIM | Neuronetics, Inc. | 20 Oct 2025 | 1 | $0 | 4 | Director | 22 Oct 2025, 16:45 |
| STIM | Neuronetics, Inc. | 22 May 2025 | 1 | $0 | 4 | Director | 27 May 2025, 17:00 |
| RGEN | REPLIGEN CORP | 15 May 2025 | 2 | $0 | 4 | Director | 19 May 2025, 20:19 |
| STIM | Neuronetics, Inc. | 07 Feb 2025 | 1 | +$99,999 | 4 | Director | 10 Feb 2025, 17:18 |
| RGEN | REPLIGEN CORP | 19 Nov 2024 | 2 | +$689,510 | 4 | Director | 20 Nov 2024, 14:29 |
| /report/000095017024107788-muir-glenn-p-2024-09-18 | G1 Therapeutics, Inc. | 18 Sep 2024 | 6 | $0 | 4 | Director | 18 Sep 2024, 16:15 |
| STIM | Neuronetics, Inc. | 05 Sep 2024 | 1 | +$20,000 | 4 | Director | 06 Sep 2024, 17:05 |
| STIM | Neuronetics, Inc. | 28 Aug 2024 | 2 | +$21,250 | 4 | Director | 30 Aug 2024, 17:15 |
| STIM | Neuronetics, Inc. | 20 Aug 2024 | 1 | +$25,000 | 4 | Director | 21 Aug 2024, 17:15 |
| STIM | Neuronetics, Inc. | 14 Aug 2024 | 1 | +$18,878 | 4 | Director | 16 Aug 2024, 17:15 |
| RGEN | REPLIGEN CORP | 01 Aug 2024 | 2 | +$181,450 | 4 | Director | 01 Aug 2024, 17:04 |
| /report/000156218024005082-muir-glenn-p-2024-06-13 | G1 Therapeutics, Inc. | 13 Jun 2024 | 2 | $0 | 4 | Director | 14 Jun 2024, 16:41 |
| STIM | Neuronetics, Inc. | 30 May 2024 | 1 | $0 | 4 | Director | 05 Jun 2024, 20:14 |
| RGEN | REPLIGEN CORP | 16 May 2024 | 2 | $0 | 4 | Director | 20 May 2024, 18:49 |
| /report/000156218023005270-muir-glenn-p-2023-06-15 | G1 Therapeutics, Inc. | 15 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 16:07 |
| STIM | Neuronetics, Inc. | 25 May 2023 | 1 | $0 | 4 | Director | 30 May 2023, 21:05 |
| RGEN | REPLIGEN CORP | 18 May 2023 | 2 | $0 | 4 | Director | 22 May 2023, 21:21 |
| /report/000156218022005350-muir-glenn-p-2022-06-23 | G1 Therapeutics, Inc. | 23 Jun 2022 | 2 | $0 | 4 | Director | 24 Jun 2022, 16:51 |
| RGEN | REPLIGEN CORP | 26 May 2022 | 2 | $0 | 4 | Director | 31 May 2022, 20:17 |
| STIM | Neuronetics, Inc. | 26 May 2022 | 1 | $0 | 4 | Director | 31 May 2022, 16:28 |
| /report/000156218021004394-muir-glenn-p-2021-06-17 | G1 Therapeutics, Inc. | 17 Jun 2021 | 2 | $0 | 4 | Director | 21 Jun 2021, 16:05 |
| STIM | Neuronetics, Inc. | 27 May 2021 | 1 | $0 | 4 | Director | 01 Jun 2021, 18:28 |
| RGEN | REPLIGEN CORP | 13 May 2021 | 2 | $0 | 4 | Director | 17 May 2021, 21:57 |